$1bn reward for new antibiotics

Drug companies should get rewards of more than $1bn for each new antibiotic they bring to the market, a report on antimicrobial resistance concludes. According to the Tackling Drug-Resistant Infections globally report $40 billion was required to fight antimicrobial resistance. The report, commissioned by the UK Prime Minister, proposes a system of market entry awards ...

Already a member?

Login to keep reading.

© 2021 the limbic